226 related articles for article (PubMed ID: 28573132)
1. Prebiotics: A Novel Approach to Treat Hepatocellular Carcinoma.
Fatima N; Akhtar T; Sheikh N
Can J Gastroenterol Hepatol; 2017; 2017():6238106. PubMed ID: 28573132
[TBL] [Abstract][Full Text] [Related]
2. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
Jiang JW; Chen XH; Ren Z; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbiota Promotes Obesity-Associated Liver Cancer through PGE
Loo TM; Kamachi F; Watanabe Y; Yoshimoto S; Kanda H; Arai Y; Nakajima-Takagi Y; Iwama A; Koga T; Sugimoto Y; Ozawa T; Nakamura M; Kumagai M; Watashi K; Taketo MM; Aoki T; Narumiya S; Oshima M; Arita M; Hara E; Ohtani N
Cancer Discov; 2017 May; 7(5):522-538. PubMed ID: 28202625
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic Fatty Liver Disease and the Gut Microbiome.
Boursier J; Diehl AM
Clin Liver Dis; 2016 May; 20(2):263-75. PubMed ID: 27063268
[TBL] [Abstract][Full Text] [Related]
5. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.
Temraz S; Nassar F; Kreidieh F; Mukherji D; Shamseddine A; Nasr R
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360566
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.
Lambert JE; Parnell JA; Eksteen B; Raman M; Bomhof MR; Rioux KP; Madsen KL; Reimer RA
BMC Gastroenterol; 2015 Dec; 15():169. PubMed ID: 26635079
[TBL] [Abstract][Full Text] [Related]
7. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
[TBL] [Abstract][Full Text] [Related]
8. The gut microbiome and liver cancer: mechanisms and clinical translation.
Yu LX; Schwabe RF
Nat Rev Gastroenterol Hepatol; 2017 Sep; 14(9):527-539. PubMed ID: 28676707
[TBL] [Abstract][Full Text] [Related]
9. The Influence of Prebiotics on Neurobiology and Behavior.
Kao AC; Harty S; Burnet PW
Int Rev Neurobiol; 2016; 131():21-48. PubMed ID: 27793220
[TBL] [Abstract][Full Text] [Related]
10. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
Liu X; Cao S; Zhang X
J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
[TBL] [Abstract][Full Text] [Related]
11. Gut Microbiome and Cancer: From Cancer Development to Therapeutics with a Special Focus on Hepatocellular Carcinoma.
Acharya S; Thirunavukkarasu C
Front Biosci (Landmark Ed); 2024 Feb; 29(2):67. PubMed ID: 38420824
[TBL] [Abstract][Full Text] [Related]
12. The role of the gut microbiome in the development and progression of liver cirrhosis and hepatocellular carcinoma.
Roderburg C; Luedde T
Gut Microbes; 2014 Jul; 5(4):441-5. PubMed ID: 25006881
[TBL] [Abstract][Full Text] [Related]
13. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
Frazier TH; DiBaise JK; McClain CJ
JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
[TBL] [Abstract][Full Text] [Related]
14. The Microbiome and Hepatocellular Carcinoma.
Rattan P; Minacapelli CD; Rustgi V
Liver Transpl; 2020 Oct; 26(10):1316-1327. PubMed ID: 32564483
[TBL] [Abstract][Full Text] [Related]
15. Early Gut Colonization With Lactobacilli and Staphylococcus in Infants: The Hygiene Hypothesis Extended.
Salminen S; Endo A; Isolauri E; Scalabrin D
J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):80-6. PubMed ID: 26230902
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation by probiotics and prebiotics in hepatocellular carcinoma.
Russo E; Fiorindi C; Giudici F; Amedei A
World J Hepatol; 2022 Feb; 14(2):372-385. PubMed ID: 35317185
[TBL] [Abstract][Full Text] [Related]
17. Can prebiotics assist in the management of cognition and weight gain in schizophrenia?
Kao AC; Burnet PWJ; Lennox BR
Psychoneuroendocrinology; 2018 Sep; 95():179-185. PubMed ID: 29883788
[TBL] [Abstract][Full Text] [Related]
18. [Liver diseases: The pathogenetic role of the gut microbiome and the potential of treatment for its modulation].
Aitbaev KA; Murkamilov IT; Fomin VV
Ter Arkh; 2017; 89(8):120-128. PubMed ID: 28914862
[TBL] [Abstract][Full Text] [Related]
19. Effects of prebiotics on immune system and cytokine expression.
Shokryazdan P; Faseleh Jahromi M; Navidshad B; Liang JB
Med Microbiol Immunol; 2017 Feb; 206(1):1-9. PubMed ID: 27704207
[TBL] [Abstract][Full Text] [Related]
20. Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake.
Pedersen C; Gallagher E; Horton F; Ellis RJ; Ijaz UZ; Wu H; Jaiyeola E; Diribe O; Duparc T; Cani PD; Gibson GR; Hinton P; Wright J; La Ragione R; Robertson MD
Br J Nutr; 2016 Dec; 116(11):1869-1877. PubMed ID: 27974055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
